QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 28, no. 1 (2009): 215-225
doi: 10.1377/hlthaff.28.1.215
© 2009 by Project HOPE
 
New Online
 * McAllen, TX & Beyond: An Expert Roundtable
 * Geography & Reform
 * Medicaid or Insurance Exchange?
 * Siren Song of New GME
 * Public Plan Option: Pro & Con
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Appendix Exhibits
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Hsu, J.
* Articles by Newhouse, J. P.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Hsu, J.
* Articles by Newhouse, J. P.
Related Collections
* Health Reform
* Managed Care - Medicare
* Medicare
* Business Of Health
* Pharmaceuticals
* Health Spending
* Consumer Issues

Health Tracking

MARKETWATCH

Distributing $800 Billion: An Early Assessment Of Medicare Part D Risk Adjustment

John Hsu, Jie Huang, Vicki Fung, Mary Price, Richard Brand, Rita Hui, Bruce Fireman, William Dow, John Bertko and Joseph P. Newhouse

The viability and stability of the Medicare Part D prescription drug program depend on accurate risk-adjusted payments. The current approach, prescription drug hierarchical condition categories (RxHCCs), uses diagnosis and demographic information to predict future drug costs. We evaluated the performance of multiple approaches for predicting 2006 Part D drug costs and plan liability. RxHCCs explain 12 percent of the variation in actual drug costs, overpredict costs for beneficiaries with low actual costs, and underpredict costs for beneficiaries with high actual costs. Combining RxHCCs with individual-level information on prior-year drug use greatly improves performance and decreases incentives for plans to select against bad risks.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Health Aff (Millwood)Home page
J. M. Donohue, H. A. Huskamp, and S. H. Zuvekas
Dual Eligibles With Mental Disorders And Medicare Part D: How Are They Faring?
Health Aff., May 1, 2009; 28(3): 746 - 759.
[Abstract] [Full Text] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2009 Project HOPE–The People-to-People Organization
Terms and Policies